News | May 04, 2009

SNM Cardiovascular Symposium Focuses on Benefits of Imaging Modalities

A example of a photoacoustic image.


May 4, 2009 - The Society of Nuclear Medicine (SNM) Symposium on Multimodality Cardiovascular Molecular Imaging convened April 30 and May 1 at the National Institutes of Health (NIH) in Bethesda, Md., to discuss the prevention of cardiac events as a critical next step toward improving cardiovascular health and patient care.

The meeting was hosted by SNM’s Molecular Imaging Center of Excellence (MICoE) with the support of NIH and of multiple corporate and nonprofit partners.

“The symposium was designed to help disseminate the latest cardiovascular imaging research and raise awareness of the most promising clinical techniques with the potential to decrease the frequency and mitigate the severity of heart attacks and other cardiac events,” said MICoE President Henry F. VanBrocklin, Ph.D., professor of radiology and director of radiopharmaceutical research at the University of California, San Francisco.

Speakers from the fields of chemistry, engineering, physics, molecular biology, cardiovascular physiology and imaging sciences focused on important lessons that can be gleaned from imaging damaged heart tissue in hopes of diagnosing potential cardiac events and preventing them before they occur.

“Changes in the structure, geometry and eventually function of the left ventricle occur following myocardial infarction, or heart attack,” said Albert J. Sinusas, M.D., professor of medicine and diagnostic radiology and director of cardiovascular nuclear imaging, Yale School of Medicine. “A targeted molecular imaging approach can provide both prognostic and diagnostic potential by revealing unique insights into molecular processes involved in repair and remodeling of the heart following a heart attack.”

During the symposium, speakers presented research about new imaging and drug delivery technologies that are currently being developed to counter the effects of atherosclerosis, or chronic inflammation of the heart’s arterial walls. According to these researchers, cardiovascular disease is the leading cause of mortality and morbidity in developed countries and atherosclerosis is a major cause of severe cardiovascular disease.

“One third of adult men and women have some form of cardiovascular disease and the estimated direct and indirect costs to our health care system exceed $400 billion,” said David K. Glover, Ph.D., associate professor of cardiovascular medicine, University of Virginia School of Medicine. “We are currently investigating an antibody-based molecular imaging probe that may be a useful and sensitive tool for advancing our understanding of the formation of atherosclerotic lesions and for the noninvasive detection of vulnerable plaques.”

Other presentations explored both the established and the leading edge in imaging techniques, from positron emission tomography (PET) and magnetic resonance (MR), to a variety of hybrid imaging modalities in biomedicine, including applications of ultrasound for medicine and nondestructive testing.

“Metabolic imaging has played a key role in diagnosis and prognostication as well as directing therapy and understanding these disease states and new therapies,” said Robert S. B. Beanlands, M.D., director of the University of Ottawa Heart Institute’s cardiac PET center. “A recent comprehensive meta-analysis confirmed that FDG PET is the most sensitive method available for predicting heart wall motion recovery and revealing improved outcomes in the healthy heart wall tissue of patients whose blood supply has been restored.”

“Photoacoustic imaging represents one of the most promising techniques for molecular imaging,” said Matthew O’Donnell, Ph.D., the Frank and Julie Jungers dean of engineering, professor of bioengineering and adjunct professor of mechanical engineering, College of Engineering at the University of Washington. “Photoacoustics combines optical and acoustic methods and can provide real-time images with molecular sensitivity at significant image depth with high spatial resolution.”

For more information: www.snm.org

Related Content

Researchers Trace Parkinson’s Damage in the Heart
News | PET Imaging | July 17, 2018
A new way to examine stress and inflammation in the heart will help Parkinson’s researchers test new therapies and...
Siemens Healthineers Announces FDA Clearance of syngo.via VB30 Molecular Imaging Software
Technology | Nuclear Imaging | July 16, 2018
At the 2018 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI), June 23-26 in Philadelphia...
SNMMI Image of the Year Highlights Theranostic Approach for Advanced Prostate Cancer

IMAGE OF THE YEAR: PSMA PET before and after lutetium-177 PSMA617 theranostics in 8 patients with metastatic prostate cancer who exhausted standard therapeutic options.

68Ga-PSMA11 PET maximum intensity projection (MIP) images at baseline and 3 months after 177Lu-PSMA617 in 8 patients with PSA decline ≥ 98 percent in a prospective phase II study. Any disease with SUV over 3 is in red. Credit: Michael Hofman, John Violet, Shahneen Sandhu, Justin Ferdinandus, Amir Iravani, Grace Kong, Aravind Ravi Kumar, Tim Akhurst, Sue Ping Thang, Price Jackson, Mark Scalzo, Scott Williams and Rodney Hicks, Peter MacCallum Cancer Centre, Melbourne, Australia.

News | PET Imaging | June 29, 2018
In the battle against metastatic castrate-resistant prostate cancer, studies have demonstrated a high response rate to...
MILabs Introduces Futuristic PET Capabilities on New VECTor6 System
Technology | PET Imaging | June 28, 2018
At the 2018 Society of Nuclear Medicine and Molecular Imaging (SNMMI) annual meeting, June 23-26, in Philadelphia,...
EchoMD AutoEF Software Improves Variability in Ejection Fraction Estimation
News | Cardiovascular Ultrasound | June 27, 2018
A recent study conducted with the Minneapolis Heart Institute found that Bay Labs’ EchoMD AutoEF deep learning software...
Philips North America and GE Healthcare Win IMV PET Imaging ServiceTrak Awards
News | PET Imaging | June 25, 2018
IMV, part of the Science and Medicine Group and a market research and business intelligence provider to the imaging...
New ASNC SPECT Imaging Guideline Addresses Advances in Myocardial Perfusion Imaging
News | SPECT Imaging | June 21, 2018
The American Society of Nuclear Cardiology (ASNC) has published an update to its 2010 guidelines for single photon...
FDA Clears New Imaging Functionalities for Biograph mCT PET/CT Systems
Technology | PET-CT | June 21, 2018
Siemens Healthineers will announce U.S. Food and Drug Administration (FDA) clearance of four new system features for...
Epsilon Imaging Demonstrates Strain Imaging Integration for Echo Programs at ASE 2018
News | Cardiovascular Ultrasound | June 19, 2018
Clinical practice, along with guidelines and research, have shown that speckle tracking strain imaging can improve...
Overlay Init